Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Innoviva Inc. (INVA)

15.51 -0.23 (-1.46%)

10-23 15:14

Open:

15.56

Pre. Close:

15.74

High:

15.75

Low:

15.36

Volume:

690,026

Market Cap:

1574M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.829 - 15.89

15.89 - 15.951

Low:

15.477 - 15.552

15.552 - 15.626

Close:

15.621 - 15.734

15.734 - 15.847

Technical analysis  (as of: 2018-10-23 2:53:11 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 18.65     One year: 21.79

Support:

Support1: 15.04    Support2: 14.46

Resistance:

Resistance1: 15.97    Resistance2: 18.65

Pivot:

15.31

Moving Averages:

MA(5): 15.54     MA(20): 15.33

MA(100): 14.55     MA(250): 14.63

MACD:

MACD(12,26): 0.16     Signal(12,26,9): 0.15

%K %D:

%K(14,3): 77.48     %D(3): 74.17

RSI:

RSI(14): 56.04

52-Week:

High: 17.99  Low: 11.47  Change(%): 31.9

Average Vol(K):

3-Month: 72060  10-Days 79689

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
INVA has closed below upper band by 38.3%. Bollinger Bands are 18.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-09-21T08:32:30-04:00
European advisory group backs expanded use for Glaxo's Trelegy Ellipta

2018-09-21T07:30:00-04:00
Trelegy Ellipta Receives Positive CHMP Opinion Supporting Expanded COPD Indication in Europe

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

101.51

Shares Float (M)

94.63

% Held by Insiders

6.40

% Held by Institutions

70.50

Shares Short (K)

12928

Shares Short Prior Month (K)

Stock Financials

EPS

1.530

EPS Est. Current Year

1.130

EPS Est. Next Year

1.930

EPS Est. Next Quarter

0.480

Forward EPS

2.190

Book Value (p.s.)

9.480

PEG Ratio

0.43

Profit Margin

76.97

Operating Margin

89.64

Return on Assets (ttm)

46.8

Return on Equity (ttm)

-73.3

Qtrly Rev. Growth

14.6

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

1.028

Qtrly Earnings Growth

55.40

Operating Cash Flow (M)

192.99

Levered Free Cash Flow (M)

129.02

Valuation

P/E

10.11

P/E Growth Ratio

-0.02

P/BV

1.63

P/S

685746624.00

P/CF

8.14

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2015-09-30

Ex-Dividend Date

2015-09-08

Forward Dividend

Last Split Date

2014-06-03

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.